Search

Your search keyword '"Huang, Yen-Hsiang"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Huang, Yen-Hsiang" Remove constraint Author: "Huang, Yen-Hsiang" Search Limiters Full Text Remove constraint Search Limiters: Full Text Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
151 results on '"Huang, Yen-Hsiang"'

Search Results

1. Sensing Antibiotics in Wastewater Using Surface-Enhanced Raman Scattering

2. Decoding the metabolic response of Escherichia coli for sensing trace heavy metals in water

4. Taiwanese junior high school 'new second generation' students : a qualitative investigation of their schooling experiences

5. Development of Rapid and Portable Detection Methods for Antibiotics, Viruses, and Antibiotic-Resistant Bacteria in Wastewater

6. Quantifying the risk of indoor drainage system in multi-unit apartment building as a transmission route of SARS-CoV-2

7. Team NCTU: Toward AI-Driving for Autonomous Surface Vehicles -- From Duckietown to RobotX

10. On Legalization of Die Bonding Bumps and Pads for 3-D ICs

13. Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib

21. Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

22. The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib

30. Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid

33. Multi-Function High-Power Converters for Smart-Grid Applications

36. Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment.

39. Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients

40. Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients

41. Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma ≤2 cm in size: A retrospective cohort study

42. The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study

50. The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Catalog

Books, media, physical & digital resources